EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening

Elvira Verduci iD, Martina Tosi iD, Juri Zuvadelli, Sara Giorda, Giacomo Biasucci iD, Vincenzo Leuzzi iD, Marco Spada iD, Alberto Burlina iD, Carlo Dionisi Vici iD, PKU Expert Group

Nutrients · 08.01.2026 · 18 (2) · 199

DOI: 10.3390/nu18020199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 08.01.2026. Verfasst von Elvira Verduci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, 20142 Milan, Italy. Hauptthemen laut MEDLINE: Phenylketonuria, Maternal, Neonatal Screening, Phenylketonurias. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The first 1000 days of life represent a critical window for growth and neurodevelopment, during which nutrition strongly influences brain development and metabolic programming. In phenylketonuria (PKU), dietary management is essential to prevent neurological impairment and later-life risk of non-communicable diseases (NCDs). This review examines current evidence on PKU from pregnancy through complementary feeding, highlighting the impact of nutritional strategies on neurodevelopmental and metabolic outcomes.

Methods

This narrative review, following PRISMA guidelines, used a systematic search of PubMed and Scopus with defined PICO questions. Original research, reviews, and guidelines on PKU nutrition during the first 1000 days were included, emphasizing neurological and metabolic outcomes.

Results

Articles addressed prenatal and postnatal factors in PKU. Optimised metabolic control in women with PKU is critical to prevent maternal PKU syndrome, reducing risks of miscarriage, congenital heart defects, microcephaly, and neurocognitive impairment. Pre-conception dietary management, frequent blood Phe monitoring, supplementation with Phe-free protein substitutes (PSs), micronutrients, and emerging pharmacological therapies support maternal and foetal health. Following newborn screening, early dietary treatment in infants with PKU maintains plasma Phe within safe ranges, promoting growth and neurodevelopment. Breastfeeding, combined with Phe-free infant PSs, is feasible, and complementary feeding should be introduced carefully. Frequent monitoring and tailored dietary adjustments, including second-stage PSs, support metabolic control, while data on gut microbiota remain limited.

Conclusions

Early multidisciplinary interventions are crucial to optimise metabolic and neurodevelopmental outcomes during this window of opportunity. Further research is needed to address remaining gaps and optimise PKU management across the first 1000 days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phenylketonuria, MaternalNeonatal ScreeningPhenylketonuriasHumansFemalePregnancyInfant, NewbornPhenylalanineBreast FeedingMaternal Nutritional Physiological Phenomena

Stichwörter der Autor:innen

breastfeedingcomplementary feedinglow-protein foodsmaternal PKUnewborn screeningphenylalaninephenylketonuriapregnancyprotein substitutes

Substanzen

Phenylalanine

Autor:innen und Institutionen

  • Department of Health Sciences, University of Milan, 20142 Milan, Italy.
  • Department of Pediatrics, Vittore Buzzi Children's Hospital, 20154 Milan, Italy.
  • Clinical Department of Pediatrics, San Paolo Hospital, ASST Santi Paolo e Carlo, 20142 Milan, Italy.
  • Department of Pediatrics, Metabolic Diseases, University of Turin, 10124 Turin, Italy.
  • Pediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
  • Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.

ORCID-Profile: Elvira Verduci, Martina Tosi, Giacomo Biasucci, Vincenzo Leuzzi, Marco Spada, Alberto Burlina, Carlo Dionisi Vici

Zitieren

APA

Verduci, E., Tosi, M., Zuvadelli, J., Giorda, S., Biasucci, G., Leuzzi, V., Spada, M., Burlina, A., Dionisi Vici, C., & PKU Expert Group (2026). The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening. Nutrients, 18(2), 199. https://doi.org/10.3390/nu18020199

Vancouver

Verduci E, Tosi M, Zuvadelli J, Giorda S, Biasucci G, Leuzzi V, et al. The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening. Nutrients. 2026;18(2):199. doi:10.3390/nu18020199

BibTeX
@article{Verduci2026,
  author = {Verduci, Elvira and Tosi, Martina and Zuvadelli, Juri and Giorda, Sara and Biasucci, Giacomo and Leuzzi, Vincenzo and Spada, Marco and Burlina, Alberto and Dionisi Vici, Carlo and PKU Expert Group, PKU Expert Group},
  title = {The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {199},
  doi = {10.3390/nu18020199}
}
Kostenlos starten →